H.R. 9979, also known as the "Scientific External Process for Educated Review of Therapeutics Act of 2024," aims to amend the Federal Food, Drug, and Cosmetic Act to create a process for science-focused drug development meetings. These meetings, led by qualified third...
Simple Explanation
H.R. 9979 is a new plan to help doctors, scientists, and people talk together about making medicines for rare illnesses. Each year, they want to have at least four big meetings where everyone shares ideas, and they have some money set aside to help pay for these talks.